These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11607820)

  • 1. The role of E2A-PBX1 in leukemogenesis.
    Aspland SE; Bendall HH; Murre C
    Oncogene; 2001 Sep; 20(40):5708-17. PubMed ID: 11607820
    [No Abstract]   [Full Text] [Related]  

  • 2. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains.
    LeBrun DP; Matthews BP; Feldman BJ; Cleary ML
    Oncogene; 1997 Oct; 15(17):2059-67. PubMed ID: 9366523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role for a single leucine residue in leukemia induction by E2A-PBX1.
    Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP
    Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo.
    Lu Q; Kamps MP
    Oncogene; 1997 Jan; 14(1):75-83. PubMed ID: 9010234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia.
    Bijl J; Krosl J; Lebert-Ghali CE; Vacher J; Mayotte N; Sauvageau G
    Oncogene; 2008 Oct; 27(49):6356-64. PubMed ID: 18679416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2A-HLF usurps control of evolutionarily conserved survival pathways.
    Seidel MG; Look AT
    Oncogene; 2001 Sep; 20(40):5718-25. PubMed ID: 11607821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
    Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
    Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.
    Bijl J; Sauvageau M; Thompson A; Sauvageau G
    Genes Dev; 2005 Jan; 19(2):224-33. PubMed ID: 15655112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
    Hirose K; Abramovich C; Argiropoulos B; Humphries RK
    Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional contribution of EEN to leukemogenic transformation by MLL-EEN fusion protein.
    Liu H; Chen B; Xiong H; Huang QH; Zhang QH; Wang ZG; Li BL; Chen Z; Chen SJ
    Oncogene; 2004 Apr; 23(19):3385-94. PubMed ID: 15077184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression.
    Hassawi M; Shestakova EA; Fournier M; Lebert-Ghali CÉ; Vaisson G; Frison H; Sinnett D; Vidal R; Thompson A; Bijl JJ
    Dev Dyn; 2014 Jan; 243(1):145-58. PubMed ID: 23996689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
    de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
    Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.
    Diakos C; Xiao Y; Zheng S; Kager L; Dworzak M; Wiemels JL
    PLoS One; 2014; 9(2):e87602. PubMed ID: 24503810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1.
    Denis CM; Chitayat S; Plevin MJ; Wang F; Thompson P; Liu S; Spencer HL; Ikura M; LeBrun DP; Smith SP
    Blood; 2012 Nov; 120(19):3968-77. PubMed ID: 22972988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA-mediated inhibition of E2A-PBX1 reduces EB-1 and Wnt16b expression in 697 pre-B leukemia cells.
    Schwaller J
    Haematologica; 2006 Jun; 91(6):724. PubMed ID: 16769568
    [No Abstract]   [Full Text] [Related]  

  • 17. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.
    Tsuzuki S; Seto M; Greaves M; Enver T
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable.
    Monica K; LeBrun DP; Dedera DA; Brown R; Cleary ML
    Mol Cell Biol; 1994 Dec; 14(12):8304-14. PubMed ID: 7969166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis.
    Chang CP; de Vivo I; Cleary ML
    Mol Cell Biol; 1997 Jan; 17(1):81-8. PubMed ID: 8972188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
    Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
    Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.